← board
MEDP
distress 1/10 · well-funded / low risk$616.02+17%today-1% from 52w high
Revenue
$707M
Liquidity
$653M
Runway
—
Shares 1y
+1%
Price & events
+1.6% over 6M
CatalystRating changeDilutionFinancingdashed = today
+16.6%
1D
+14.5%
1W
+30.1%
1M
+56.6%
3M
+4.8%
6M
+40.8%
1Y
+72.4%
2Y
+238.2%
5Y
+358.3%
All
Overview
- Market Cap
- $17.59B
- Volume
- 263.40K
- 52 Week Range
- $309 – $621
- Total Shares
- 28.56M
- Float Shares
- 22.47M
- Short %
- 9.23%
- % Held by Insiders
- 19.43%
- % Held by Institutions
- 87.17%
- RVOL
- 0.82x
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 2
- 2026-07-22Confirmed 100%earningsEarningsEarnings releaseyahoo
- 2025-02-06partnershipBoard approved $600 million increase to stock repurchase programSEC 8-K
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
hold · target $472 (-23% upside) · 12 analysts
- 2026-07-13MizuhoOutperform
- 2026-07-08BairdOutperform → Neutral
- 2026-07-07JefferiesBuy → Hold
- 2026-04-24RBC CapitalOutperform
- 2026-04-24BMO CapitalMarket Perform
- 2026-04-24BairdOutperform
Competitors
- none identified
Recent news
- 2026-07-23Medpace Holdings stock hits all-time high at 649.5 USD By Investing.com - Investing.com Canada
- 2026-07-23Medpace Holdings, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:MEDP) 2026-07-23 - Seeking Alpha
- 2026-07-23S&P 500 Futures Fall In Premarket Trading; Medpace Holdings, Allegion Lead - Moomoo
- 2026-07-23S&P 500 Futures Fall in Premarket Trading; Medpace Holdings, Allegion Lead - Barron's
- 2026-07-23Medpace Holdings, Inc. Stock 12‑Month Price Target Raised to $490.36, Implies 7% Downside - TradingView
- 2026-07-23Medpace Holdings, Inc. Reports Second Quarter 2026 Results - BioSpace
- 2026-07-23Medpace (MEDP) Q3 2025 earnings summary - Quartr
- 2026-07-23MEDP: Medpace Holdings Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.